Cancer Biology and Therapy

Published by: Taylor & Francis Group  

People

  1. Lindsten
    Lindsten

Groups

Search Within
  1. "2012"
Formats
  1. Journal Article (1)
People
  1. Tullia Lindsten (1)
Years
  1. 2012 (1)
Publishers
  1. Taylor & Francis Group (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia
    Journal Article

    Karar, J.; Cerniglia, G. J.; Lindsten, T.; Koumenis, C.; Maity, A.
    Cancer Biology and Therapy (2012)

    Fulltext@MSK | Save

    • Cancer Biology and Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Biology & Therapy 1538-4047 Landes Bioscience
    Cancer Biology & Therapy 1538-4047 Taylor & Francis Group
    Cancer biology & therapy 1555-8576 Landes Bioscience
    Cancer biology & therapy 15558576 Unknown
    Cancer Biology and Therapy 1538-4047 Taylor & Francis Group
    Cancer Biology and Therapy 1538-4047 Taylor & Francis Group
    Cancer Biology and Therapy 1538-4047 Taylor & Francis Group
    Cancer Biology and Therapy 15558576 Landes Bioscience
    Cancer Biology and Therapy 15384047 Unknown
    Cancer Biology and Therapy 1555-8576 Landes Bioscience
    Cancer Biology and Therapy 15384047 2019, © 2019 Taylor & Francis Group, Llc
    Cancer Biology and Therapy 15384047 Landes Bioscience